Richard Marais (R Marais)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 17

Top Venues

Nature communications

Nature reviews. Cancer

Nature medicine

Oncogene

Cancer Research UK Manchester Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Cancer Research UK Manchester Institute Feb 01 2012

United Kingdom

Director & Group Leader :: Molecular Oncology

Publications

Patricia P Centeno, Valeria Pavet, Richard Marais
The journey from melanocytes to melanoma. Nature reviews. Cancer (2023)
Sjors M Kas, Piyushkumar A Mundra, Duncan L Smith, Richard Marais
Functional classification of DDOST variants of uncertain clinical significance in congenital disorders of glycosylation. Scientific reports 13 (1) (2023)
Patricia P Centeno, Valeria Pavet, Richard Marais
The journey from melanocytes to melanoma. Nature reviews. Cancer (2023)
Patricia P Centeno, Valeria Pavet, Richard Marais
The journey from melanocytes to melanoma. Nature reviews. Cancer (2023)
Martin Eden, Robert Hainsworth, Louisa G Gordon, Tracy Epton, Paul C Lorigan, Lesley E Rhodes, Richard Marais, Adéle C Green, Katherine Payne
Cost-effectiveness of a policy-based intervention to reduce melanoma and other skin cancers associated with indoor tanning. The British journal of dermatology 187 (1) (2022)
A Cannistraci, Pauline Hascoet, Adnan Ali, P Mundra, N W Clarke, V Pavet, Richard Marais
MiR-378a inhibits glucose metabolism by suppressing GLUT1 in prostate cancer. Oncogene 41 (10) (2022)
Sara Valpione, Piyushkumar A Mundra, Elena Galvani, Luca Giovanni Campana, Paul C Lorigan, Francesco De Rosa, Avinash Gupta, John Weightman, Sarah Mills, Nathalie Dhomen, Richard Marais
The T cell receptor repertoire of tumor infiltrating T cells is predictive and prognostic for cancer survival. Nature communications 12 (1) (2021)
Piyushkumar A Mundra, Nathalie Dhomen, Manuel J Rodrigues, Lauge Hjorth Mikkelsen, Nathalie Cassoux, Kelly Brooks, Sara Valpione, Jorge Sergio Reis-Filho, Steffen Heegaard, Marc-Henri Stern, Sergio Roman-Roman, Richard Marais
Ultraviolet radiation drives mutations in a subset of mucosal melanomas. Nature communications 12 (1) (2021)
Sara Valpione, Piyushkumar A Mundra, Elena Galvani, Luca Giovanni Campana, Paul C Lorigan, Francesco De Rosa, Avinash Gupta, John Weightman, Sarah Mills, Nathalie Dhomen, Richard Marais
Author Correction: The T cell receptor repertoire of tumor infiltrating T cells is predictive and prognostic for cancer survival. Nature communications 12 (1) (2021)
Nathalie Dhomen, Piyushkumar A Mundra, Richard Marais
Sunglasses to hide behind may also prevent melanoma of the eyes. British journal of cancer 125 (4) (2021)
Elena Galvani, Piyushkumar A Mundra, Sara Valpione, Pablo Garcia-Martinez, Matthew Smith, Jonathan Greenall, Rohit Thakur, Beth Helmink, Miles C Andrews, Louis Boon, Christopher Chester, Gabriela Gremel, Kate Hogan, Amit Mandal, Kang Zeng, Antonia Banyard, Garry Ashton, Martin Cook, Paul C Lorigan, Jennifer A Wargo, Nathalie Dhomen, Richard Marais
Stroma remodeling and reduced cell division define durable response to PD-1 blockade in melanoma. Nature communications 11 (1) (2020)
Dominic G Rothwell, Mahmood Ayub, Natalie Cook, Fiona Thistlethwaite, Louise Carter, Emma Dean, Nigel Smith, Shaun Villa, Joanne Dransfield, Alexandra Clipson, Daniel White, Kamrun Nessa, Saba Ferdous, Matthew Howell, Avinash Gupta, Bedirhan Kilerci, Sumitra Mohan, Kris Frese, Sakshi Gulati, Crispin Miller, Allan Jordan, Helen Eaton, Nicholas Hickson, Ciara O'Brien, Donna Graham, Claire Kelly, Sreeja Aruketty, Robert Metcalf, Jaseela Chiramel, Nadina Tinsley, Alexander J Vickers, Roopa Kurup, Hannah Frost, Julie Stevenson, Siobhan Southam, Dónal Landers, Andrew Wallace, Richard Marais, Andrew M Hughes, Ged Brady, Caroline Dive, Matthew G Krebs
Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study. Nature medicine 25 (5) (2019)
Michael P Smith, Sareena Rana, Jennifer Ferguson, Emily J Rowling, Keith T Flaherty, Jennifer A Wargo, Richard Marais, Claudia Wellbrock
A PAX3/BRN2 rheostat controls the dynamics of BRAF mediated MITF regulation in MITFhigh /AXLlow melanoma. Pigment cell & melanoma research 32 (2) (2018)
Lucas D Trucco, Piyushkumar A Mundra, Kate Hogan, Pablo Garcia-Martinez, Amaya Viros, Amit K Mandal, Nicolas Macagno, Caroline Gaudy-Marqueste, Donald Allan, Franziska Baenke, Martin Cook, Clare McManus, Berta Sanchez-Laorden, Nathalie Dhomen, Richard Marais
Ultraviolet radiation-induced DNA damage is prognostic for outcome in melanoma. Nature medicine 25 (2) (2018)
HaoRan Tang, Leo Leung, Grazia Saturno, Amaya Viros, Duncan Smith, Gianpiero Di Leva, Eamonn Morrison, Dan Niculescu-Duvaz, Filipa Lopes, Louise Johnson, Nathalie Dhomen, Caroline Springer, Richard Marais
Lysyl oxidase drives tumour progression by trapping EGF receptors at the cell surface. Nature communications 8 (2017)
Patrizia Cammareri, Aidan M Rose, David F Vincent, Jun Wang, Ai Nagano, Silvana Libertini, Rachel A Ridgway, Dimitris Athineos, Philip J Coates, Angela McHugh, Celine Pourreyron, Jasbani H S Dayal, Jonas Larsson, Simone Weidlich, Lindsay C Spender, Gopal P Sapkota, Karin J Purdie, Charlotte M Proby, Catherine A Harwood, Irene M Leigh, Hans Clevers, Nick Barker, Stefan Karlsson, Catrin Pritchard, Richard Marais, Claude Chelala, Andrew P South, Owen James Sansom, Gareth J Inman
Inactivation of TGFβ receptors in stem cells drives cutaneous squamous cell carcinoma. Nature communications 7 (2016)
Koorosh Korfi, M Smith, J Swan, T C P Somervaille, N Dhomen, Richard Marais
BIM mediates synergistic killing of B-cell acute lymphoblastic leukemia cells by BCL-2 and MEK inhibitors. Cell death & disease 7 (2016)

Richard Marais.css-eqlu8i{font-size:small;padding-left:4px;} (R Marais)

Publication Activity (10 Years)

Top Topics

Top Venues

Richard Marais (R Marais)